A3292012
6,11-Dihydro-11-oxodibenzo[b,e]oxepin-2-acetic Acid , 97% , 55453-87-7
Synonym(s):
(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid;Isoxepac;NSC 300907
CAS NO.:55453-87-7
Empirical Formula: C16H12O4
Molecular Weight: 268.26
MDL number: MFCD00242952
EINECS: 611-268-9
Pack Size | Price | Stock | Quantity |
1G | RMB32.00 | In Stock |
|
5G | RMB72.80 | In Stock |
|
25G | RMB164.00 | In Stock |
|
100g | RMB568.80 | In Stock |
|
500g | RMB2173.60 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 130-132°C |
Boiling point: | 528.2±50.0 °C(Predicted) |
Density | 1.39 g/cm3 |
storage temp. | Sealed in dry,Room Temperature |
solubility | soluble in Methanol |
form | Solid |
pka | 4.24±0.10(Predicted) |
color | White to Light yellow to Light orange |
Merck | 14,5237 |
InChIKey | QFGMXJOBTNZHEL-UHFFFAOYSA-N |
Description and Uses
Isoxepac is a non-steroidal anti-inflammatory with analgesic and antipyretic activity. It is more slowly absorbed and eliminated in the rat and rabbit after oral dosing than in the dog, rhesus monkey and man.It can be used to treat allergic rhinitis, urticaria, and skin diseases with itching symptoms.
Safety
Symbol(GHS) | GHS06 |
Signal word | Danger |
Hazard statements | H301+H311-H315-H319 |
Precautionary statements | P501-P270-P264-P280-P337+P313-P305+P351+P338-P361+P364-P332+P313-P301+P310+P330-P302+P352+P312-P405 |
Hazard Codes | T |
Risk Statements | 25-62 |
Safety Statements | 36/37-45 |
RIDADR | UN 2811 6.1 / PGIII |
RTECS | HQ4110000 |
HazardClass | 6.1 |
PackingGroup | III |
HS Code | 2932996560 |
Toxicity | LD50 orally in rats: 199 mg/kg (Ueno) |